The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Open accessAbstract
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included 1) identification and monitoring, 2) cardiovascular disease and management of dyslipidemia, 3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, 4) glycemia measurement, hypoglycemia, and drug therapies, 5) nutrition and general care in advanced-stage chronic kidney disease, 6) children and adolescents, and 7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (64,65).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (63,64).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
In the citing paper
“There is no evidence that adjusting the daily level of protein intake (typically 1-1.5 g/kg body wt/day or 15-20% total calories) will improve health, and research is inconclusive regarding the ideal amount of dietary protein to optimize either glycemic management or CVD risk (159,195).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedAhmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Self-citationBrenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Flagged first, then by citations
2 of the 193 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,000
Circular RNAs in human diseases
Wang, Y., Zhang, J., Yang, Y. S. H., Liu, Z., Sun, S., Li, R. F., Zhu, H., Tian, L., Zheng, J., Li, J., et al. (2024) · MedComm · doi:10.1002/mco2.699 · Cited by 41
Yamamoto, C. M., Murakami, T., Oakes, M., Mitsuhashi, M., Kelly, C., Henry, R. R., & Sharma, K. (2018) · American Journal of Nephrology · doi:10.1159/000489129 · Cited by 41
El-sayed, M. S., Elbadawy, A., Abdelmonem, A. A., Omar, R., & Mohamed, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.017 · Cited by 40
Galindo, R. J., Pasquel, F. J., Fayfman, M., TSEGKA, K. G., Dhruv, N., Cardona, S., Wang, H., Vellanki, P., & Umpierrez, G. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000763 · Cited by 39
Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
Farah, R., Al-Sabbagh, M. Q., Momani, M. S., Albtoosh, A. S., Arabiat, M., Abdulraheem, A., Aljabiry, H., & Abufaraj, M. M. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02429-4 · Cited by 39
The residual cardiorenal risk in type 2 diabetes
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01229-2 · Cited by 40
Lo, C., Ilić, D., Teede, H. J., Fulcher, G., Gallagher, M., Kerr, P. G., Murphy, K., Polkinghorne, K. R., Russell, G. M., Usherwood, T., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0262-2 · Cited by 38
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side
Dieter, B. P., Alicic, R. Z., & Tuttle, K. R. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00211.2018 · Cited by 39
Self-citationDasgupta, P., Kumar, V., Krishnaswamy, P. R., & Bhat, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c02997 · Cited by 38
Mitophagy in Diabetic Kidney Disease
Zhang, X., Feng, J., Li, X., Wu, D., Wang, Q., Li, S., & Shi, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.778011 · Cited by 38
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Fan, G., Gong, T., Lin, Y., Wang, J., Sun, L., Wei, H., Yang, X., Liu, Z., Li, X., Zhao, L., et al. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09338-6 · Cited by 38
Electrochemical Skin Conductance in Diabetic Kidney Disease
Freedman, B. I., Smith, S. C., Bagwell, B. M., Xu, J., Bowden, D. W., & Divers, J. (2015) · American Journal of Nephrology · doi:10.1159/000437342 · Cited by 37
Lv, T., Lu, Y., Liu, Y., Feng, H., Li, C., Sheng, W., Cui, Z., Zhu, S., Gu, X., Yang, Z., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6691226 · Cited by 37
Fritzen, T. M., Weinert, L. S., Denk, I. B., Deuschle, J. A. S., Conte, I. S., Menegolla, M. P., & Rodrigues, T. D. C. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000386 · Cited by 37
Amatruda, M., Gembillo, G., Giuffrida, A. E., Santoro, D., & Conti, G. (2021) · Medicina · doi:10.3390/medicina57090868 · Cited by 38
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons Learned
Neumiller, J. J., Alicic, R. Z., & Tuttle, K. R. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.02.001 · Cited by 37
Self-citationGaddy, A. R., Elrggal, M. E., Madariaga, H. M., Kelly, A., Lerma, E. V., & Colbert, G. B. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101848 · Cited by 40
Wu, B., Zhang, S., Lin, H., & Mou, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12653 · Cited by 39
MicroRNA and Diabetic Complications: A Clinical Perspective
Fan, B., Luk, A. O. Y., Chan, J. C. N., & Ronald, C. W. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7318 · Cited by 37
Wang, T., Zhong, H., Lian, G., Cai, X., Gong, J., Ye, C., & Xie, L. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000500782 · Cited by 37
Chang, L., Wang, Q., Ju, J., Li, Y., Cai, Q., Hao, L., & Zhou, Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.580406 · Cited by 37
Cai, R., Li, C., Zhao, Y., Yuan, H., Zhang, X., Liang, A., & Yi, Y. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01150-w · Cited by 37
Short Leukocyte Telomere Length Predicts Albuminuria Progression in Individuals With Type 2 Diabetes
Gurung, R. L., Yiamunaa, M., Liu, S., Liu, J., & Lim, S. C. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.12.005 · Cited by 36
Chu, L., Fuller, M. T., Jervis, K., Ciaccia, A., & Abitbol, A. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.07.015 · Cited by 36
Kalantar‐Zadeh, K., Rhee, C. M., Joshi, S., Brown-Tortorici, A., & Kramer, H. M. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000761 · Cited by 38
Self-citationAssociations of multiple plasma metals with chronic kidney disease in patients with diabetes
Wang, R., Long, T., He, J., Xu, Y., Wei, Y., Zhang, Y., He, X., & He, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114048 · Cited by 36
Review of 2017 Diabetes Standards of Care
Crawford, K. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.07.010 · Cited by 41
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD
Galindo, R. J., de Boer, I. H., Neumiller, J. J., & Tuttle, K. R. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04510422 · Cited by 35
Self-citationKaminski, C. Y., Galindo, R. J., Navarrete, J. E., Zabala, Z. E., Moazzami, B., Gerges, A., McCoy, R. G., Fayfman, M., Vellanki, P., Idrees, T., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1276 · Cited by 35
Wang, J., Yu, Y., Li, X., Dong, L., Xu, C., Yuan, J., Wei, S., Li, X., YANG, K. Y., Zheng, D., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3046 · Cited by 36
Diabetes Management in Older Adults With Chronic Kidney Disease
Clemens, K. K., O’Regan, N., & Rhee, J. J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1128-3 · Cited by 35
Zhang, H., Hu, W., & Zhang, G. K. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02509-8 · Cited by 35
Wanner, C., Inzucchi, S. E., Zinman, B., Koitka‐Weber, A., Mattheus, M., George, J. T., von Eynatten, M., Hauske, S. J., & EMPA‐REG OUTCOME Investigators (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14158 · Cited by 35
How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR
García-Carro, C., Vergara, A., Bermejo, S., Azancot, M. A., Sánchez-Fructuoso, A. I., de la Nieta, M. D. S., Agraz, I., & Soler, M. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112505 · Cited by 35
Urinary Extracellular Vesicles: Potential Biomarkers of Renal Function in Diabetic Patients
Kamińska, A., Platt, M., Kasprzyk, J., Kuśnierz‐Cabala, B., Gala‐Błądzińska, A., Woźnicka, O., Jany, B. R., Krok, F., Piekoszewski, W., Kuźniewski, M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5741518 · Cited by 35
Tong, L., & Adler, S. G. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1457397 · Cited by 36
Mather, K. J., Bebu, I., Baker, C., Cohen, R. M., Crandall, J. P., DeSouza, C., Green, J. B., Kirkman, M. S., Krause-Steinrauf, H., Larkin, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108235 · Cited by 34
Cook, S., Schmedt, N., Broughton, J., Kalra, P. A., Tomlinson, L. A., & Quint, J. K. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065927 · Cited by 35
Management of Hyperglycemia in Diabetic Kidney Disease
Neumiller, J. J., & Hirsch, I. B. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.3.214 · Cited by 34
Self-citationWang, J., Li, H., Tan, M., Gao, G., Zhang, Y., Ding, B., Su, X., Kong, X., & Ma, J. (2019) · Oncotarget · doi:10.18632/oncotarget.26265 · Cited by 34
Makvandi, K., Hockings, P. D., Jensen, G., Unnerstall, T., Leonhardt, H., Jarl, L., Englund, C., Francis, S., Sundgren, A. K., Hulthe, J., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac054 · Cited by 34
Kouidi, E. J., Hanssen, H., Anding‐Rost, K., Cupisti, A., Deligiannis, A. P., Grupp, C., Koufaki, P., Leeson, P., Segura‐Ortí, E., Craenenbroeck, A. H. V., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae130 · Cited by 38
Jia, Y., Song, N., Mao, R., Li, J., Zhang, Q., Huang, Y., Zhang, L., Han, H., Ding, Y., & Xu, L. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00325 · Cited by 33
Zhou, X., Zou, J., Ao, C., Gong, D., Chen, X., & Ma, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105192 · Cited by 33
Boonphang, O., Ontawong, A., Pasachan, T., Phatsara, M., Duangjai, A., Amornlerdpison, D., Jinakote, M., & Srimaroeng, C. (2021) · Molecules · doi:10.3390/molecules26071907 · Cited by 33
Nassirpour, R., Raj, D., Townsend, R. R., & Argyropoulos, C. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.02.018 · Cited by 33
Mihardja, L. K., Delima, D., Massie, R. G. A., Karyana, M., Nugroho, P., & Yunir, E. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0338-6 · Cited by 33
Glycated albumin and risk of mortality in the US adult population
Rooney, M. R., Daya, N., Tang, O., McEvoy, J. W., Coresh, J., Christenson, R. H., & Selvin, E. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvab232 · Cited by 32
Tuttle, K. R., Bain, S. C., Bosch‐Traberg, H., Khunti, K., Rasmussen, S., Sokareva, E., & Cherney, D. Z. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.04.028 · Cited by 32
Self-citationXu, W., Ge, Q., Liu, A., Li, Y., & Zou, H. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.232801 · Cited by 35
Mishriky, B. M., Powell, J. R., Wittwer, J. A., Chu, J., Sewell, K. B., Wu, Q., & Cummings, D. M. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13805 · Cited by 32
Griffin, T. P., O’Shea, P. M., Smyth, A., Islam, M. N., Wall, D., Ferguson, J. P., O'Sullivan, E., Finucane, F. M., Dinneen, S. F., Dunne, F., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002125 · Cited by 32
Azegami, T., Nakayama, T., Hayashi, K., Hishikawa, A., Yoshimoto, N., Nakamichi, R., & Itoh, H. (2021) · Diabetes · doi:10.2337/db20-1257 · Cited by 32
Real-World Diagnosis and Treatment of Diabetic Kidney Disease
Rodríguez, F., Lee, D. J., Gad, S. S., Santos, M. P., Beetel, R. J., Vasey, J. J., Bailey, R. A., Patel, A. A., Blais, J. D., Weir, M. R., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01777-9 · Cited by 32
Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013–2017
Paik, J. M., Zhuo, M., York, C., Tsacogianis, T., Kim, S. C., & Desai, R. J. (2021) · American Journal of Nephrology · doi:10.1159/000520028 · Cited by 32
Fibre Intake in Chronic Kidney Disease: What Fibre Should We Recommend?
Guldris, S. C., Catalá, J. L. T., Amado, A., Granados, N. M., & Varela, E. P. (2022) · Nutrients · doi:10.3390/nu14204419 · Cited by 35
Reinhart, G. A., Harrison, P. C., Lincoln, K., Chen, H., Sun, P., Hill, J., Qian, H. S., McHugh, M., Clifford, H., Ng, K. J., et al. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001423 · Cited by 32
Asao, T., Oki, K., Yoneda, M., Tanaka, J., & Kohno, N. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0360 · Cited by 32
Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq
Rubín, A., Salzberg, A. C., Kawasawa, Y. I., Grivitishvilli, A., & Tombran‐Tink, J. (2016) · BMC Genomics · doi:10.1186/s12864-016-3199-8 · Cited by 32
Pavkov, M. E., Harding, J. L., Chou, C.-F., & Saaddine, J. B. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.10.019 · Cited by 31
Xu, Y., Dong, S., Fu, E. L., Sjölander, A., Grams, M. E., Selvin, E., & Carrero, J. J. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.03.007 · Cited by 31
He, J., Liu, B., Du, X., Wei, Y., Kong, D., Feng, B., Guo, R., Asiamah, E. A., Griffin, M. D., Hynes, S. O., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03647-x · Cited by 33
Ding, Y., Li, H., Yang, L., Liu, D., Zhang, L., Wang, T., Liu, T., & Ma, L. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5205903 · Cited by 31
Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes
Mamilly, L., Mastrandrea, L. D., Vasquez, C. M., Klamer, B. G., Kallash, M., & Aldughiem, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.669954 · Cited by 31
Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
Chen, A., Wang, H., Su, Y., Zhang, C., Qiu, Y., Zhou, Y., Wan, Y., Hu, B., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.720466 · Cited by 31
Lo, C. H., Teede, H. J., Fulcher, G. R., Gallagher, M., Kerr, P. G., Ranasinha, S., Russell, G. M., Walker, R. G., & Zoungas, S. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0493-x · Cited by 31
Lo, C., Toyama, T., Oshima, M., Jun, M., Chin, K. L., Hawley, C. M., & Zoungas, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub3 · Cited by 30
Wang, S.-Z., Zhang, Y., & Shi, H. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.08.005 · Cited by 30
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Piko, N., Bevc, S., Hojs, R., & Ekart, R. (2024) · Pharmaceuticals · doi:10.3390/ph17040418 · Cited by 32
Rroji, M., Spahia, N., Figurek, A., & Spasovski, G. B. (2025) · Biomedicines · doi:10.3390/biomedicines13030728 · Cited by 31
Chiang, C., Ueng, K.-C., Chao, T., Lin, T., Wu, Y.-J., Wang, K.-L., Sung, S., Yeh, H., Li, Y., Liu, P., et al. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000359 · Cited by 30
Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling
Wu, W., Huang, X. R., You, Y., Xue, L., Wang, X., Meng, X., Lin, X., Shen, J., Yu, X., Lan, H.-Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61647 · Cited by 32
SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
Klen, J., & Dolžan, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071995 · Cited by 30
Deng, X., Zhao, L., Guo, C. Y., Yang, L., Wang, D., Li, Y., Xia, H., Wang, C., Cai, Z., Li, L., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s283413 · Cited by 30
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes
Gimblet, C. J., Kruse, N. T., Geasland, K. M., Michelson, J., Sun, M., Mandukhail, S. R., Wendt, L. H., Eyck, P. T., Pierce, G. L., & Jalal, D. I. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000337 · Cited by 32
McElfish, P. A., Narcisse, M., Long, C. R., Ayers, B. L., Hawley, N. L., Aitaoto, N., Riklon, S., Su, L. J., Ima, S., Wilmoth, R. O., et al. (2017) · Journal of Community Genetics · doi:10.1007/s12687-017-0313-9 · Cited by 30
Cannabinoid Receptors in Diabetic Kidney Disease
Barutta, F., Mastrocola, R., Bellini, S., Bruno, G., & Gruden, G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0975-7 · Cited by 29
Curovic, V. R., Hansen, T. W., Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Persson, F., Parving, H., & Rossing, P. R. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1205-0 · Cited by 29
Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
Felício, J. S., Silva, L. D. S. D., Martins, C. L. E. L. P., Neto, J. F. A., de Lemos, M. N., Resende, F. D. S., da Silva, W. M., de Alcântara, A. L., de Oliveira, M. C. N. I., Neto, N. J. K. D. S., et al. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0380-z · Cited by 29
Du, Y. N., Dennis, B., Ramirez, V., Li, C., Wang, J., & Meireles, C. L. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02717-7 · Cited by 29
Vitamin D Deficiency, Chronic Kidney Disease and Periodontitis
Ganimusa, I., Chew, E. Y., & Lu, E. M. (2024) · Medicina · doi:10.3390/medicina60030420 · Cited by 35
Yang, Y., Miao, C., Wang, Y., He, J., & Bo, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3830 · Cited by 29
Seidu, S., Barratt, J., & Khunti, K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.02.006 · Cited by 30
Urine E-cadherin: A Marker for Early Detection of Kidney Injury in Diabetic Patients
Koziolek, M. J., Muller, G. A., Dihazi, G. H., Jung, K., Altubar, C., Wallbach, M., Markovic, I., Raddatz, D., Jahn, O., Karaköse, H., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030639 · Cited by 30
Podocyte-specific knockin of PTEN protects kidney from hyperglycemia
Wang, H., Feng, Z., Xie, J., Wen, F., Jv, M., Liang, T., Li, J., Wang, Y., Zuo, Y., Li, S., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00575.2017 · Cited by 28
Shi, L., Xue, Y., Yu, X., Wang, Y., Hong, T., Li, X., Ma, J., Zhu, D., & Mu, Y. (2024) · JMIR Public Health and Surveillance · doi:10.2196/54429 · Cited by 30
Consensus statement on insulin therapy in chronic kidney disease
Rajput, R., Sinha, B., Majumdar, S., Shunmugavelu, M., & Bajaj, S. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.032 · Cited by 28
Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: A meta‐analysis
Ye, X., Luo, T., Wang, K., Wang, Y., Yang, S., Li, Q., & Hu, J. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3195 · Cited by 28
Zhang, Y., Shen, X., He, L., Zhao, F., & Yan, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108096 · Cited by 28
den Bulck, S. V., Vankrunkelsven, P., Goderis, G., Pottelbergh, G. V., Swerts, J., Panis, K., & Hermens, R. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01788-8 · Cited by 28
Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
Fernández‐Fernández, B., Mahíllo, I., Sánchez-Rodríguez, J. E., Carriazo, S. M., Sanz, A. B., Sánchez-Niño, M. D., & Ortíz, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061611 · Cited by 28
Huang, Y., Li, R., Zhang, L., Chen, Y., Dong, W., Zhao, X., Yang, H., Zhang, S., Xie, Z., Ye, Z., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.579296 · Cited by 28
Liu, Y., Hu, Z., Xing, H., Kang, L., Chen, X., Liu, B., & Niu, K. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.074 · Cited by 28
Liu, M., Di, Y. M., May, B. H., Zhang, A. L., Zhang, L., Chen, J., Wang, R., Liu, X., & Xue, C. C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155646 · Cited by 28
Aspectos celulares y moleculares de la nefropatía diabética, rol del VEGF-A
Carranza, K., Verón, D., Cercado, A. G., Bautista, N., Pozo, W., Tufró, A., & Verón, D. (2015) · Nefrología · doi:10.1016/j.nefro.2015.05.013 · Cited by 28
Yan, M., Wen, Y., Yang, L., Wu, X., Lu, X., Zhang, B., Huang, W., & Li, P. (2016) · Trials · doi:10.1186/s13063-016-1385-2 · Cited by 28
Yeoh, E. C. K., Lim, B. K., Fun, S., Tong, J. T., Yeoh, L. Y., Sum, C. F., Subramaniam, T., & Lim, S. C. (2016) · Nephrology · doi:10.1111/nep.12978 · Cited by 28
Kim, S. S., Song, S. H., Kim, J. H., Jeon, Y. K., Kim, B. H., Kang, M., Chun, S. W., Hong, S. H., Chung, M., Kim, Y. K., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13360 · Cited by 28
Karoli, R., Siddiqi, Z., Kaul, A., Fatima, J., Varshney, S., & Beg, M. (2017) · Annals of African Medicine · doi:10.4103/aam.aam_12_17 · Cited by 28
Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis
Iyengar, R., Franzese, J., & Gianchandani, R. Y. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1044-y · Cited by 28
Metadata
- Authors
- Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., Neumiller, J. J., Patel, U. D., Ratner, R. E., Whaley-Connell, A. T., & Molitch, M. E.
- Affiliations
- University of Washington (US)
- National Kidney Foundation (US)
- Newcastle University (GB)
- American Diabetes Association (US)
- Division of Nephrology, University of Washington, Seattle, WA
- Sierra Nevada Nephrology Consultants, Reno, NV
- School of Medicine, University of California, Irvine, Irvine, CA
- National Institutes of Health (US)
- Cleveland Clinic (US)
- Washington State University Spokane (US)
- Duke University (US)
- Harry S. Truman Memorial Veterans Hospital, Columbia, MO, and Department of Internal Medicine, Division of Nephrology and Hypertension, University of Missouri School of Medicine, Columbia, MO
- Northwestern University (US)
- Corresponding author
- Chiang, Jane L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2864-2883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4170131
- OpenAlex
- W2072070798
- Semantic Scholar
- 0c6864a569d8918ea51eda33aae122cff819ac65
- Cited by
- 1,153
- References
- 193
- Citations by year
- 2026: 90 · 2025: 104 · 2024: 107 · 2023: 131 · 2022: 128 · 2021: 118 · 2020: 130 · 2019: 87 · 2018: 87 · 2017: 72 · 2016: 65 · 2015: 27 · 2014: 6
- FWCI
- 44.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Gilead Sciences
- Halozyme
- Luitpold Pharmaceuticals
- Angion
- Novo Nordisk
- CSL Limited
- National Institutes of Health (UL1TR000430)
- Relypsa
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- diabetic nephropathy, end-stage renal disease, type 2 diabetes, chronic kidney disease, cardiovascular disease, dyslipidemia, hypertension, renin-angiotensin-aldosterone system blockade, mineralocorticoid receptor antagonists, glycemic control, hypoglycemia, pharmacotherapy, pediatric diabetes, multidisciplinary care, patient-centered medical home, health care delivery
- MeSH terms
- Adolescent, Aged, Antihypertensive Agents, Blood Glucose, Cardiovascular Diseases, Child, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Kidney Function Tests, Middle Aged, Incidence, Prevalence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
